Artificial intelligence in anti-dengue drug development

Abstract

Dengue fever is a mosquito-borne illness that affects millions of people worldwide. Artificial intelligence (AI) is being employed in the battle against it. AI is being used to analyse dengue immune repertoires, which may yield hitherto unheard-of insights into the complexities of dengue adaptive immunity, help in the development of novel treatments, and influence the creation of vaccines. This AI-driven strategy may contribute to the creation of dengue fever therapies that are more potent.

Keywords

Dengue / Dengue virus / Anti-dengue / Artificial intelligence

References

[1] Lee MF, Wu YS, Poh CL. Molecular mechanisms of antiviral agents against dengue virus. Viruses. 2023;15(3):705.

[2] García-Ariza LL, González-Rivillas N, Díaz-Aguirre CJ, Rocha-Roa C, Padilla-Sanabria L, Castaño-Osorio JC. Antiviral activity of an indole-type compound derived from natural products, identified by virtual screening by interaction on dengue virus NS5 protein. Viruses. 2023;15(7):1563.

[3] He X, Zheng Y, Tian C, et al. Quassinoids from Eurycoma longifolia with antiviral activities by inhibiting dengue virus replication. Phytomedicine. 2023;110:154650.

[4] Gautam S, Thakur A, Rajput A, Kumar M. Anti-dengue: a machine learning-assisted prediction of small molecule antivirals against dengue virus and implications in drug repurposing. Viruses. 2023;16(1):45.

[5] Natali EN, Babrak LM, Miho E. Prospective artificial intelligence to dissect the dengue immune response and discover therapeutics. Front Immunol. 2021;12:574411.

[6] Moshiri J, Constant DA, Liu B, et al. A targeted computational screen of the SWEETLEAD database reveals FDA-approved compounds with anti-dengue viral activity. mBio. 2020;11(6):10–1128.

[7] Soares LB, Silva-Júnior EF, Moreira KA, Aquino PG. Natural products for controlling dengue and its vectors. Stud Nat Prod Chem. 2022;72:423–464.

[8] Altamish M, Khan M, Baig MS, et al. Therapeutic potential of medicinal plants against dengue infection: a mechanistic viewpoint. ACS Omega. 2022;7(28):24048–24065.

[9] Putri GN, Gudla CS, Singh M, et al. Expanding the anti-flaviviral arsenal: discovery of a baicalein-derived Compound with potent activity against DENV and ZIKV. Antivir Res. 2023;220:105739.

[10] Nair V, Chi G, Shu Q, Julander J, Smee DF. A heterocyclic molecule with significant activity against dengue virus. Bioorg Med Chem Lett. 2009;19(5):1425–1427.

[11] Zhou Z, Khaliq M, Suk JE, et al. Antiviral compounds discovered by virtual screening of small – molecule libraries against dengue virus E protein. ACS Chem Biol. 2008;3(12):765–775.

[12] Khalili NSD, Khawory MH, Salin NH, et al. Synthesis and biological activity of imidazole phenazine derivatives as potential inhibitors for NS2B-NS3 dengue protease. Heliyon. 2024;10(2):e24202.

[13] Bajrai LH, Faizo AA, Alkhaldy AA, Dwivedi VD, Azhar EI. Repositioning of anti-dengue compounds against SARS-CoV-2 as viral polyprotein processing inhibitor. PLoS One. 2022;17(11):e0277328.

[14] Jainul Fathima A, Revathy R, Balamurali S, Murugaboopathi G. Prediction of denguehuman protein interaction using artificial neural network for anti-viral drug discovery. In: Proceedings of International Conference on Sustainable Computing in Science, Technology and Management (SUSCOM). Jaipur-India: Amity University Rajasthan;2019.

RIGHTS & PERMISSIONS

2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.